Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Multiple Sclerosis (MS) is a chronic, inflammatory and demyelinating disease of the central nervous system. It is a heterogeneous pathology that can follow different clinical courses, which may be led by distinct effector mechanisms. Limited and controversial information has been reported in relation to the progression of the immune response across MS phenotypes. Here, we aimed to determine differences in cytokine levels, cell frequencies and their ratios among different MS clinical subtypes. Blood samples from untreated patients diagnosed with clinically isolated syndrome (CIS) (n=21), different clinical forms of MS (n=62) [relapsing remitting (RRMS), secondary progressive (SPMS) and primary progressive (PPMS)], and healthy controls (HC) (n=17), were tested for plasma levels of IFN-γ, IL-10, TGF-β, IL-17A, and IL-17F by immunoanalysis. Th1 and Th17 lymphocyte frequencies were determined by flow cytometry. Our results showed that IFN- levels and the IFN-γ/IL-10 ratio were significantly higher in CIS patients than in RRMS and HC. Th1 cell frequencies were significantly higher in CIS and RRMS than in progressive MS. The Th1/Th17 cell ratio was significantly skewed toward Th1 in CIS compared to RRMS, SPMS, PPMS and HC. The Th17 cell frequency was significantly higher in RRMS compared to CIS. Receiver operating characteristic (ROC) statistical analysis determined that IFN-γ, the IFN-γ/IL-10 ratio, Th1 cell frequency and the Th1/Th17 cell ratio discriminated among CIS and MS subtypes. A subanalysis among patients expressing high IL-17F levels showed that RRMS and PPMS patients had a polarization toward Th17 compared to CIS and HC, and IL-17F and the IFN-γ/IL-17F ratio discriminated between disease subtypes. Overall, our data shows that CIS and MS phenotypes display distinct Th1 and Th17-related cytokine and cell profiles. These immune parameters discriminated between clinical forms and suggested a shift from Th1 into Th17 across MS subtypes. Upon validation, they might be useful as biomarkers to predict disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Th17 cells are long lived and retain a stem cell-like molecular signature
Muranski, P., Borman, Z. A., Kerkar, S. P., Klebanoff, C. A., Ji, Y., Sanchez-Perez, L., Sukumar, M., Reger, R. N., Yu, Z., Kern, S. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.019 · Cited by 443
Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study
The North American Study Group on Interferon beta-1b in Secondary Progressive MS (2004) · Neurology · doi:10.1212/01.wnl.0000146958.77317.3e · Cited by 423 · cited 1×
“This conclusion is supported by the lack of effectiveness of current anti-inflammatory and disease-modifying therapies (DMTs), such as treatment with interferon (IFN)-β, after transition to SPMS (6, 7), and PPMS (8).”
BackgroundHuman T H 17 Cells Are Long-Lived Effector Memory Cells
Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J., Klimczak, A., Lange, A., & Zou, W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002949 · Cited by 278
Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis
Tejera-Alhambra, M., Casrouge, A., de Andrés, C., Seyfferth, A., Ramos-Medina, R., Alonso, B., Vega, J., Fernández-Paredes, L., Albert, M. L., & Sánchez-Ramón, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128952 · Cited by 55 · cited 3×
“The majority of the studies have compared RRMS and progressive MS (11, 28–30), have analyzed a combination of treated and untreated patients (15, 16, 31), or have analyzed the spontaneous production of cytokines by unstimulated PBMC cultured in vitro for 24 h (17).”
BackgroundResult
Cited by
Kölliker-Frers, R., Udovin, L., Otero-Losada, M., Kobiec, T., Herrera, M. I., Palacios, J., Razzitte, G., & Capani, F. (2021) · Mediators of Inflammation · doi:10.1155/2021/9999146 · Cited by 258
“In fl ammatory mediators like cytokines dependent on the Th1, Th17 lymphocyte sub-population [175], NO, or free radicals [176, 177] have been observed during clinical relapse phases in MS. Conversely, suppressive cellular activity by Th2, Th3, and Tr1 cells, in particular, has been reported during…”
Inflammation in multiple sclerosis
Haase, S., & Linker, R. A. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211007687 · Cited by 183
Heinrich, M. J., Purcell, C. A., Pruijssers, A. J., Zhao, Y., Spurlock, C. F., Sriram, S., Ogden, K. M., Dermody, T. S., Scholz, M. B., Crooke, P. S., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.02.003 · Cited by 41
Complete Freund’s adjuvant as a confounding factor in multiple sclerosis research
Lazarević, M., Stanisavljević, S., Nikolovski, N., Dimitrijević, M., & Miljković, Đ. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353865 · Cited by 21
Insights and challenges on animal models for progressive multiple sclerosis
Nalepa, I. F., Haahr, N. O., Bekiaris, V., Jakobsen, M. R., Asuni, A. A., & Benmamar-Badel, A. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03805-3 · Cited by 1
“Changes in the Th1/ Th17 ratio have in the past been believed to be majorly implicated in MS pathology [58].”
Metadata
- Authors
- Arellano, G., Acuña, E., Reyes, L. I., Ottum, P. A., De Sarno, P., Villarroel, L., Ciampi, E., Uribe-San Martín, R., Cárcamo, C., & Naves, R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-06-30
- Volume
- 8
- Pages
- 753-753
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2727607698
- Cited by
- 70
- References
- 7
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.